CN1090464C - Health-care hypoglycermic edble salt and its preparing method - Google Patents
Health-care hypoglycermic edble salt and its preparing method Download PDFInfo
- Publication number
- CN1090464C CN1090464C CN98120142A CN98120142A CN1090464C CN 1090464 C CN1090464 C CN 1090464C CN 98120142 A CN98120142 A CN 98120142A CN 98120142 A CN98120142 A CN 98120142A CN 1090464 C CN1090464 C CN 1090464C
- Authority
- CN
- China
- Prior art keywords
- salt
- calcium
- zinc
- health
- care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title abstract description 5
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 35
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 12
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 12
- 239000011651 chromium Substances 0.000 claims abstract description 12
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 11
- 239000011701 zinc Substances 0.000 claims abstract description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 8
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 6
- 235000019341 magnesium sulphate Nutrition 0.000 claims abstract description 6
- 239000001103 potassium chloride Substances 0.000 claims abstract description 6
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 6
- 239000011575 calcium Substances 0.000 claims description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
- 229960005069 calcium Drugs 0.000 claims description 8
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229940092124 calcium citrate malate Drugs 0.000 claims description 5
- MPCMQXRREZMSPJ-UHFFFAOYSA-L calcium;2-hydroxybutanedioate;2-hydroxypropane-1,2,3-tricarboxylic acid;pentahydrate Chemical compound O.O.O.O.O.[Ca+2].[O-]C(=O)C(O)CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O MPCMQXRREZMSPJ-UHFFFAOYSA-L 0.000 claims description 5
- 150000001845 chromium compounds Chemical class 0.000 claims description 5
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 5
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 5
- 239000011781 sodium selenite Substances 0.000 claims description 5
- 235000015921 sodium selenite Nutrition 0.000 claims description 5
- 229960001471 sodium selenite Drugs 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 4
- HPCCGRCEBFBZQP-UHFFFAOYSA-N chromium;pyridine-3-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CN=C1 HPCCGRCEBFBZQP-UHFFFAOYSA-N 0.000 claims description 4
- 150000003751 zinc Chemical class 0.000 claims description 4
- DTGBCAFLVSFZRF-UHFFFAOYSA-N 2-aminoacetic acid;chromium Chemical compound [Cr].NCC(O)=O DTGBCAFLVSFZRF-UHFFFAOYSA-N 0.000 claims description 3
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 3
- 239000011746 zinc citrate Substances 0.000 claims description 3
- 235000006076 zinc citrate Nutrition 0.000 claims description 3
- 229940068475 zinc citrate Drugs 0.000 claims description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 2
- 239000001354 calcium citrate Substances 0.000 claims description 2
- 229960004256 calcium citrate Drugs 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 229960002449 glycine Drugs 0.000 claims description 2
- 229940001447 lactate Drugs 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 2
- 239000011670 zinc gluconate Substances 0.000 claims description 2
- 235000011478 zinc gluconate Nutrition 0.000 claims description 2
- 229960000306 zinc gluconate Drugs 0.000 claims description 2
- 239000011576 zinc lactate Substances 0.000 claims description 2
- 235000000193 zinc lactate Nutrition 0.000 claims description 2
- 229940050168 zinc lactate Drugs 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- 238000012858 packaging process Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 12
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000011669 selenium Substances 0.000 abstract description 4
- 229910052711 selenium Inorganic materials 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 208000001491 myopia Diseases 0.000 abstract description 3
- 230000004379 myopia Effects 0.000 abstract description 3
- 239000011734 sodium Substances 0.000 abstract description 3
- 229910052708 sodium Inorganic materials 0.000 abstract description 3
- 208000002177 Cataract Diseases 0.000 abstract description 2
- 208000019622 heart disease Diseases 0.000 abstract description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 208000013016 Hypoglycemia Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 229940091258 selenium supplement Drugs 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000130270 Fagopyrum tataricum Species 0.000 description 1
- 235000014693 Fagopyrum tataricum Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- BFGKITSFLPAWGI-UHFFFAOYSA-N chromium(3+) Chemical compound [Cr+3] BFGKITSFLPAWGI-UHFFFAOYSA-N 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000015219 food category Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000021400 peanut butter Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention discloses health-care hypoglycemic edible salt and a preparing method thereof, which belongs to the food field. The health-care hypoglycemic edible salt is characterized in that glucose tolerance factors (GTF)-trivalent chromium, and microelements of selenium, zinc and iodine are added to low sodium double salt composed of edible refined salt, potassium chloride, magnesium sulfate and calcium salt to be thoroughly mixed and uniformly prepared into the health-care hypoglycemic edible salt. The health-care hypoglycemic edible salt has the advantages of scientific prescription, low cost, simple process, etc. The health-care hypoglycemic edible salt has obvious hypoglycemic effect, no toxicity or harm and no hypoglycemia generation. The present invention has ideal effects on treating diabetes, heart disease, hypertension, hyperlipoidemia, cancers, nearsightedness, cataract, etc.
Description
The present invention relates to a kind of blood sugar reducing health salt and compound method thereof, belong to the food category.
100,000,000 polysaccharide urine patient is arranged at present in the world approximately, and about 95% the non-insulin-depending type that belongs to is a type ii diabetes.Along with the raising of people's living standard and the adjustment of diet structure, the incidence of disease of diabetes increases year by year, is threatening that people's is healthy.In case ill, follow all the life mostly.This disease is again and the disease of " eating " close ties that though also there are some to aim at the food of diabetes patient's exploitation, effect is not ideal mostly.Announced that as hypoglycemic biscuit, sugar reducing milk powder (CN1101502A), CN1161801A GTF strengthens melbine, GTF strengthens peanut butter etc., but can not use as the staple food of three meals in a day.CN1179888A has announced a kind of sugar-reducing nutritious flour, but mainly is to add the low tartary buckwheat powder of sugar, can influence the absorption of nutritional labeling, and effect is not too obvious.
The edible everyday salt of people as carrier, for human body replenishes necessary element or material, plays treatment and health-care effect with salt, and this is a kind of new function of salt, and its development is extremely rapid.Functional health class salt mainly contains iodized salt in the market, adds calcium salt (CN1099943A), selenium-adding anti-cancer salt (CN1161165A), balanced health salt (CN1099944A) etc.CN1134249A has also announced a kind of compound method of healthy salt in addition, is rich zinc, rich iodine, rich calcium type equally.In the market still not with salt as carrier, prevent and treat the special-purpose hypoglycemic salt of diabetes (II).
Diabetology studies have shown that with nutrition both at home and abroad: the generation of diabetes is relevant with the shortage of trace element chromium, zinc with development, and scarce chromium has become diabetes and the obvious main cause that improves of the cardiovascular disease incidence of disease.Beijing Hospital Jiang state man of virtue and ability etc. proves in clinical research: trivalent chromium is the good nutritious supplementary pharmaceutical of type ii diabetes people, replenish the biologically active that chromium can increase insulin for the type ii diabetes people, improve patient's sugar tolerance (practical diabetology, P130-139, the Jiang Guoyan chief editor, in October, 1992, the People's Health Publisher).The diabetic should note zinc supplementation (Chinese food newspaper, Li Weiping, on December 22nd, 1,996 three editions).Chromium: the trace element of pre-myopia prevention (Chinese food newspaper, Xin Keming, on May 28th, 1997).Experimental results show that both at home and abroad: the low high potassium of sodium has the effect that suppresses the hypertension development in the diet.Human body lacks selenium can cause angiocardiopathy and cancer.Diabetes not only have multiple metabolic disorder, and the complication of blood vessel, cardiac muscle, nerve, kidney and eye is arranged.
The objective of the invention is to salt is carrier, provides a kind of and starts with from nutrition and functional components, and both zinc supplementations, calcium, iodine, selenium, chromium (III) have the functional table salt of health-care effects such as hypoglycemic, step-down, anti-cancer again.
The object of the present invention is achieved like this:
At first with sodium selenite, KI, zinc salt, trivalent chromium compound, pouring mixer according to proportioning into a certain amount of salt mixes, make it to become the female salt of the high concentration that mixes, weigh salt, potassium chloride, magnesium sulfate, the calcium salt that crushes according to formula rate then, together pour they and female salt into mixer and carry out secondary and fully mix, through metering, packing and finished product.Its formula for a product percentage by weight is as follows:
Edible refined salt 55～80
Potassium chloride 15～30
Magnesium sulfate 6～12
Calcium salt (in Ca) 0.5～3
Trivalent chromium compound is (with Cr
3+Meter) 0.0005～0.01
KI 0.003～0.007
Sodium selenite 0.007～0.0035
Zinc salt (in Zn) 0.012～0.1
Wherein calcium salt is calcium carbonate, calcium activated, calcium lactate, calcium citrate, calcium citrate malate (CCM) etc., but calcium citrate malate (CCM) and calcium activated are more desirable; Zinc salt is zinc sulfate, zinc lactate, zinc gluconate, zinc citrate, glycine zine etc., but zinc citrate and glycine zine are more desirable; Trivalent chromium compound is Chromic lactate, ascorbic acid chromium, glycine chromium, glutamic acid chromium, nicotinic acid chromium, but more preferably glycine chromium and nicotinic acid chromium.
The invention has the advantages that:
1, with salt as carrier, strengthen scientifically and rationally and added GTF (GTF)-trivalent chromium compound, trace elements of selenium, iodine, zinc reduce sodium, improve the intake of potassium, magnesium, make salt have the functional health effect.
2, this product is not only adjuvant therapy of diabetes patient's functional food, and heart disease, hypertension, hyperlipidemia, cancer, myopia and cataract etc. are all had desirable effect.
3, this product is cheap, has no side effect, and edible everyday, health-care effects such as hypoglycemic are obvious, and production technology is simple, is easy to promote edible.Thereby hypoglycemic salt has vast potential for future development and remarkable social benefit and economic benefit.
Specific embodiments of the invention:
For example produce 10 tons of blood sugar reducing health salt.
At first take by weighing after sodium selenite 200g, the KI 500g, glycine zine 15Kg, nicotinic acid chromium 2.3Kg, the table salt 82Kg that crush put into mixer and fully mix, make the female salt of 100Kg high concentration; Secondly, take by weighing and pulverize oven dry good table salt 6700Kg, potassium chloride 2200Kg, magnesium sulfate 800Kg, calcium activated 200Kg, in mixer, carry out secondary with the female salt of 100Kg high concentration and fully mix, obtain 10 tons of blood sugar reducing health salt, measure at last, pack and be finished product.
Claims (3)
1. blood sugar reducing health salt, it is characterized in that: it is by following composition and proportioning, formulated through pulverizing, batching, mixing, metering, packaging process processing, its formula for a product percentage by weight is as follows:
Edible refined salt 55～80
Potassium chloride 15～30
Magnesium sulfate 6～12
Calcium 0.5～3
Trivalent chromium 0.0005～0.01
KI 0.003～0.007
Sodium selenite 0.007～0.0035
Zinc 0.012～0.1
More than the percentage by weight summation of each composition be 100%.
2. according to claim 1, the source of calcium is calcium carbonate, calcium activated, calcium lactate, calcium citrate, calcium citrate malate; The source of zinc is zinc sulfate, zinc lactate, zinc gluconate, zinc citrate, glycine zine; Chromic source is Chromic lactate, ascorbic acid chromium, glycine chromium, glutamic acid chromium, nicotinic acid chromium.
3. the blood sugar reducing health salt according to claim 1, it is characterized in that: at first with sodium selenite, KI, zinc salt, trivalent chromium compound, pouring mixer according to proportioning into a certain amount of salt mixes, make it to become the female salt of the high concentration that mixes, weigh salt, potassium chloride, magnesium sulfate, the calcium salt that crushes according to formula rate then, together pour they and female salt into mixer and carry out secondary and fully mix, through metering, packing and finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98120142A CN1090464C (en) | 1998-10-09 | 1998-10-09 | Health-care hypoglycermic edble salt and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98120142A CN1090464C (en) | 1998-10-09 | 1998-10-09 | Health-care hypoglycermic edble salt and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1250616A CN1250616A (en) | 2000-04-19 |
| CN1090464C true CN1090464C (en) | 2002-09-11 |
Family
ID=5226624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98120142A Expired - Fee Related CN1090464C (en) | 1998-10-09 | 1998-10-09 | Health-care hypoglycermic edble salt and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1090464C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101049150B (en) * | 2006-07-25 | 2010-09-15 | 陈治先 | Edible nourishment health care potassium salt with extensive use |
| CN101380115B (en) * | 2008-10-27 | 2011-11-16 | 买世禄 | Production method of health food rich in glucose sugar tolerance factor chrome |
| CN105212172A (en) * | 2014-05-29 | 2016-01-06 | 谈丽娜 | A kind of blood sugar reducing health salt and preparation method thereof |
| CN108371317A (en) * | 2018-02-06 | 2018-08-07 | 天津佰亿达企业管理股份有限公司 | A kind of person in middle and old age's salt and preparation method thereof |
| CN108402440A (en) * | 2018-02-06 | 2018-08-17 | 天津佰亿达企业管理股份有限公司 | A kind of selenium-rich Yikang edible salt and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161165A (en) * | 1997-01-09 | 1997-10-08 | 孔增科 | Selenium salt for preventing cancer |
-
1998
- 1998-10-09 CN CN98120142A patent/CN1090464C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161165A (en) * | 1997-01-09 | 1997-10-08 | 孔增科 | Selenium salt for preventing cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1250616A (en) | 2000-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102077936B (en) | Special sea dietary food for diabetics | |
| CN107897905A (en) | A kind of hypoglycemic nutrition powder and its preparation method and application | |
| CN102067960A (en) | Health-care rice suitable for diabetics and processing method thereof | |
| CN102077939B (en) | Marine special dietary food special for fat people | |
| CN101589777A (en) | A kind of composite rice and preparation method thereof | |
| CN109007800A (en) | A kind of specific full nutritional formulas and preparation method thereof for diabetic | |
| CN105876585A (en) | Protein solid beverage and preparation method and application thereof | |
| CN102077940A (en) | Special dietary marine food for patients with coronary heart disease | |
| CN108617778A (en) | A kind of weight losing meal-replacing milk shake and preparation method thereof | |
| CN102077945A (en) | Special dietary seafood for postabortal and postpartum women | |
| CN108391811A (en) | A kind of tumour full nutrition formula food and its application | |
| CN106165905B (en) | A kind of calcium adds vitamine soft capsule and preparation method | |
| CN1090464C (en) | Health-care hypoglycermic edble salt and its preparing method | |
| CN107048329A (en) | A kind of zinc-rich health-care salt and preparation method thereof | |
| CN105558244A (en) | Food assisting in reducing blood lipid, reducing blood sugar and improving immunity and preparation method of food | |
| CN103141603B (en) | Brown rice tea and preparation method thereof | |
| CN107028149A (en) | A kind of rich iron health-care salt and preparation method thereof | |
| CN101711565A (en) | Donkey-hide glue yam powder | |
| CN107299266A (en) | A kind of daily necessities health care composite and preparation method thereof | |
| CN102077943A (en) | Seafood for special dietary uses for hypomnesia patients | |
| CN1317262A (en) | Nutritive spiruline noodles and making technology thereof | |
| CN101129406A (en) | Formula of compound colla carapaeis corii asini series products and method for producing the same | |
| CN100515430C (en) | Pharmaceutical preparation for supplementing calcium, magnesium and vitamin D | |
| CN101548778A (en) | Food with weight-losing function | |
| CN102578455A (en) | Blood sugar and blood fat-reducing health-care effervescent preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |